ARKGvsIBTF
ARK GENOMIC REVOLUTION ETF against iShares iBonds Dec 2025 Term Treasury ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| ARKG | IBTF | |
|---|---|---|
| Expense ratio | 0.75% | 0.070% |
| Assets | $1.4B | $1.4B |
| Net flow, 1 month | — | — |
| Net flow, 1 year | — | −$367M |
| Return, YTD | +73.1% | — |
| Return, 1 year | +67.1% | -0.0% |
| Avg daily volume | 4.7M | — |
| Holdings | 44 | 32 |
| Listed | Oct 31, 2014 | Feb 25, 2020 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS